{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:05:13Z","timestamp":1780311913722,"version":"3.54.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Antibiot."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Interpretation of urine culture results requires key clinical information such as symptom status, catheterization, and multidrug-resistant organism (MDRO) risk. However, this information is frequently absent from routine request forms, contributing to overtreatment of asymptomatic bacteriuria (ASB) and suboptimal antimicrobial prescribing. This study evaluated the impact of implementing a structured urine-culture request form as part of a diagnostic and therapeutic stewardship program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective, non-randomized interventional study was conducted at an 1800-bed tertiary-care hospital in India (March 2023\u2013March 2024). Patients undergoing urine culture testing in Urology\/Nephrology departments used a structured request form capturing symptoms, risk factors, and clinical context (test arm), while General Medicine continued routine forms (control arm). Primary outcomes included ASB treatment, MDRO detection, recurrence, and guideline-concordant prescribing. Patients were followed for one year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 484 patients were included (198 test arm, 286 control arm). Antibiotic treatment for ASB was significantly lower in the test arm compared with the control arm (3.6% vs 67.0%; p &amp;lt; 0.001), without adverse outcomes. Guideline-compliant prescribing was higher in the test arm (73.7% vs 26.2%; p &amp;lt; 0.001). MDRO prevalence was higher in the test arm (32.2% vs 11.3%), reflecting greater clinical complexity rather than the intervention itself. Recurrent urinary tract infection (UTI) within one year was significantly lower in the test arm (14.1% vs 29.0%; p &amp;lt; 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Introducing a structured urine-culture request form improved diagnostic clarity and antibiotic prescribing, particularly by reducing unnecessary treatment of ASB and increasing guideline compliance, without compromising patient outcomes. This low-cost intervention represents a practical and scalable diagnostic stewardship strategy for improving UTI management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/frabi.2026.1793784","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:25:35Z","timestamp":1780309535000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of a structured urine culture request form on antimicrobial stewardship in urinary tract infections at a tertiary care hospital in India"],"prefix":"10.3389","volume":"5","author":[{"given":"Supreeta R","family":"Shettar","sequence":"first","affiliation":[{"name":"Department of Microbiology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research (AHER)","place":["Mysuru, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahadevaiah Neelambike","family":"Sumana","sequence":"additional","affiliation":[{"name":"Department of Microbiology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research (AHER)","place":["Mysuru, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjunath S","family":"Shetty","sequence":"additional","affiliation":[{"name":"Deptartment of Nephrology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research (AHER)","place":["Mysuru, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogeesh D","family":"Maheshwarappa","sequence":"additional","affiliation":[{"name":"Department of Microbiology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research (AHER)","place":["Mysuru, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghukanth","family":"Reddy","sequence":"additional","affiliation":[{"name":"Deptartment of Nephrology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research (AHER)","place":["Mysuru, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Srinivasan","sequence":"additional","affiliation":[{"name":"Division of Nanoscience and Technology, School of Life Sciences, JSS Academy of Higher Education and Research (AHER)","place":["Mysuru, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Kalyatanda","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease and Global Medicine, Department of Medicine","place":["Gainesville, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amruthraj G","family":"Gowda","sequence":"additional","affiliation":[{"name":"Department of Urology, JSS Medical College and Hospital, JSS Academy of Higher Education and Research (AHER)","place":["Mysuru, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012799","article-title":"STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration","volume":"6","author":"Cohen","year":"2016","journal-title":"BMJ Open"},{"key":"B3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1017\/ice.2014.41","article-title":"Antimicrobial stewardship in outpatient settings: a systematic review","volume":"36","author":"Drekonja","year":"2015","journal-title":"Infect. Control Hosp Epidemiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx207","article-title":"Inappropriate management of asymptomatic patients with positive urine cultures: a systematic review and meta-analysis","volume":"4","author":"Flokas","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1056\/nejmcp1104429","article-title":"Clinical practice. Uncomplicated urinary tract infection","volume":"366","author":"Hooton","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jhin.2020.10.027","article-title":"Diagnostic stewardship programme for urine culture: impact on antimicrobial prescription in a multi-center cohort","volume":"108","author":"Lee","year":"2021","journal-title":"J. Hosp Infect."},{"key":"B8","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/cid\/ciu010","article-title":"Reducing antimicrobial therapy for asymptomatic bacteriuria among noncatheterized inpatients: a proof-of-concept study","volume":"58","author":"Leis","year":"2014","journal-title":"Clin. Infect. Dis. Off. Publ Infect. Dis. Soc Am."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace","volume":"215","author":"Logan","year":"2017","journal-title":"J. Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1001\/jama.2017.8531","article-title":"Diagnostic stewardship-leveraging the laboratory to improve antimicrobial use","volume":"318","author":"Morgan","year":"2017","journal-title":"JAMA."},{"key":"B11","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.ijantimicag.2006.05.010","article-title":"Asymptomatic bacteriuria: review and discussion of the IDSA guidelines","volume":"28","author":"Nicolle","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1086\/427507","article-title":"Infectious diseases society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults","volume":"40","author":"Nicolle","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1093\/cid\/ciy1121","article-title":"Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America","volume":"68","author":"Nicolle","year":"2019","journal-title":"Clin. Infect. Dis. Off. Publ Infect. Dis. Soc Am."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1001\/jamainternmed.2019.2871","article-title":"Risk factors and outcomes associated with treatment of asymptomatic bacteriuria in hospitalized patients","volume":"179","author":"Petty","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cmi.2023.03.010","article-title":"Understanding how diagnostics influence antimicrobial decision-making is key to successful clinical trial design","volume":"29","author":"Rawson","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"B16","article-title":"Urine culture","volume-title":"StatPearls [Internet]","author":"Sinawe","year":"2025"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","article-title":"Association of adverse events with antibiotic use in hospitalized patients","volume":"177","author":"Tamma","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1001\/jamainternmed.2017.1938","article-title":"Antimicrobial stewardship: another focus for patient safety","volume":"27","author":"Tamma","year":"2014","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/QCO.0000000000000077","article-title":"Rethinking how antibiotics are prescribed: incorporating the 4 moments of antibiotic decision making into clinical practice","volume":"321","author":"Tamma","year":"2019","journal-title":"JAMA."},{"key":"B20","doi-asserted-by":"publisher","first-page":"568.e1","DOI":"10.1016\/j.jamda.2012.04.004","article-title":"Antibiotic use and resistance in long term care facilities","volume":"13","author":"van Buul","year":"2012","journal-title":"J. Am. Med. Dir Assoc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e4499","DOI":"10.1093\/cid\/ciaa1372","article-title":"Antibiotic overuse after hospital discharge: a multi-hospital cohort study","volume":"73","author":"Vaughn","year":"2021","journal-title":"Clin. Infect. Dis. Off. Publ Infect. Dis. Soc Am."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1086\/383029","article-title":"Laboratory diagnosis of urinary tract infections in adult patients","volume":"38","author":"Wilson","year":"2004","journal-title":"Clin. Infect. Dis. Off. Publ Infect. Dis. Soc Am."}],"container-title":["Frontiers in Antibiotics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frabi.2026.1793784\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:25:36Z","timestamp":1780309536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frabi.2026.1793784\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":22,"alternative-id":["10.3389\/frabi.2026.1793784"],"URL":"https:\/\/doi.org\/10.3389\/frabi.2026.1793784","relation":{},"ISSN":["2813-2467"],"issn-type":[{"value":"2813-2467","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"article-number":"1793784"}}